Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

230 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis.
Krakauer M, Sorensen PS, Sellebjerg F. Krakauer M, et al. Among authors: sellebjerg f. J Neuroimmunol. 2006 Dec;181(1-2):157-64. doi: 10.1016/j.jneuroim.2006.09.006. Epub 2006 Nov 1. J Neuroimmunol. 2006. PMID: 17081623 Clinical Trial.
Peptide specificity of anti-myelin basic protein antibodies in patients with acute optic neuritis and the HLA system.
Sellebjerg F, Frederiksen JL, Olsson T, Link H, Madsen HO, Ryder LP, Svejgaard A. Sellebjerg F, et al. Scand J Immunol. 1994 Jun;39(6):575-80. doi: 10.1111/j.1365-3083.1994.tb03415.x. Scand J Immunol. 1994. PMID: 7516573
Intrathecal activation of the complement system and disability in multiple sclerosis.
Sellebjerg F, Jaliashvili I, Christiansen M, Garred P. Sellebjerg F, et al. J Neurol Sci. 1998 May 7;157(2):168-74. doi: 10.1016/s0022-510x(98)00086-0. J Neurol Sci. 1998. PMID: 9619641
Costimulatory CD80 (B7-1) and CD86 (B7-2) on cerebrospinal fluid cells in multiple sclerosis.
Sellebjerg F, Jensen J, Ryder LP. Sellebjerg F, et al. J Neuroimmunol. 1998 Apr 15;84(2):179-87. doi: 10.1016/s0165-5728(97)00261-0. J Neuroimmunol. 1998. PMID: 9628461
Soluble ICAM-1, demyelination, and inflammation in multiple sclerosis and acute optic neuritis.
Petersen AA, Sellebjerg F, Frederiksen J, Olesen J, Vejlsgaard GL. Petersen AA, et al. Among authors: sellebjerg f. J Neuroimmunol. 1998 Aug 1;88(1-2):120-7. doi: 10.1016/s0165-5728(98)00103-9. J Neuroimmunol. 1998. PMID: 9688333
Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS.
Sellebjerg F, Frederiksen JL, Nielsen PM, Olesen J. Sellebjerg F, et al. Neurology. 1998 Aug;51(2):529-34. doi: 10.1212/wnl.51.2.529. Neurology. 1998. PMID: 9710030 Clinical Trial.
MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis.
Sellebjerg F, Christiansen M, Garred P. Sellebjerg F, et al. Mult Scler. 1998 Jun;4(3):127-31. doi: 10.1177/135245859800400307. Mult Scler. 1998. PMID: 9762660 Clinical Trial.
Intrathecal synthesis of free immunoglobulin light chains in multiple sclerosis.
Krakauer M, Schaldemose Nielsen H, Jensen J, Sellebjerg F. Krakauer M, et al. Among authors: sellebjerg f. Acta Neurol Scand. 1998 Sep;98(3):161-5. doi: 10.1111/j.1600-0404.1998.tb07287.x. Acta Neurol Scand. 1998. PMID: 9786611
Cerebrospinal fluid measures of disease activity in patients with multiple sclerosis.
Sellebjerg F, Christiansen M, Nielsen PM, Frederiksen JL. Sellebjerg F, et al. Mult Scler. 1998 Dec;4(6):475-9. doi: 10.1177/135245859800400603. Mult Scler. 1998. PMID: 9987755
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.
Sørensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM. Sørensen TL, et al. Among authors: sellebjerg f. J Clin Invest. 1999 Mar;103(6):807-15. doi: 10.1172/JCI5150. J Clin Invest. 1999. PMID: 10079101 Free PMC article.
230 results
Jump to page
Feedback